Volume response are more significant and important than flow response to bronchodilator in patients with COPD Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009
Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020
Evaluation of vibration response imaging (VRI) in COPD and asthma patients before and after bronchodilators Source: Eur Respir J 2007; 30: Suppl. 51, 100s Year: 2007
Flow-volume responsiveness to bronchodilators in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003
Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 240s Year: 2002
Evaluation of inspiratory flow rates in stable severe COPD patients Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010
Emphysema phenotype predicts pattern of exercise response to bronchodilators in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 109s Year: 2005
Effect of He-O2 breathing and inhaled salbutamol on expiratory flow limitation and dynamic hyperinflation in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002
Adherence of stable COPD patients to inhaled pharmacotherapy Source: Annual Congress 2011 - COPD management Year: 2011
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD Source: Annual Congress 2010 - COPD: management Year: 2010
Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD Source: Annual Congress 2004 - Exercise and systemic effects in COPD Year: 2004
Non-contact assessment of acute bronchodilator’ response during tidal breathing in COPD patients using structured light plethysmography (SLP) Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
COPD subtypes most likely to benefit from inhaled corticosteroids (ICS): Cluster analysis Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012